Sunshine Biopharma Inc. - SBFM Future Profit

SBFM (sunshinebiopharma.com) - company brandmark

Sunshine Biopharma is strengthening its oncology portfolio through partnerships with research centers, enhancing its investment attractiveness. The forward profitability trend visualizes the dynamics of expected revenues, where 0.00 expresses the latest metric level. Business stability relies on generic drug production and innovation, while the precision of drug series is guaranteed by the strict calibration of production lines.

SBFM: sunshinebiopharma.com Future Profit 04/11/2024 - 08/19/2026

Sunshine Biopharma - analytical breakdowns and key metrics (SBFM)

Fundamental company analysis:SBFM, Sunshine Biopharma Inc.
Core merchandise of Sunshine Biopharma Inc.

Projected earnings reflect the fundamental business development vector via the consolidated market consensus. This metric is calculated as the expected difference between future revenues and operating expenses, reacting sensitively to every reporting update. By analyzing the projected earnings trend, an investor determines the asset's degree of overheating and the issuer's stability. For Sunshine Biopharma (SBFM), this indicator depends directly on the success of oncology therapy commercialization. The upward curve confirms market confidence in the efficacy of breast cancer drugs.

Competitor analysis

Future Profit ONC|HALO: Expected Net Income|Future Profit RVMD (RevMed)|AAPG (Ascentage) - Expected Net Income|Projected Future Earnings CGON (cgoncology.com)|URGN - Future Profit|BCAX: Future Profit|PSNL - Projected Future Earnings|Erasca Corp (ERAS) - Expected Profit|Delcath - Expected Net Income|YMAB (Y-mAbs Therapeutics Inc) - Projected Future Earnings|Expected Net Profit Aura Biosciences, Inc. AURA|Projected Future Earnings CADL|Projected Future Earnings Accuray (ARAY)|Expected Profit SELLAS Life Sciences Group Inc. SLS|ACTU - Future Profit|CTOR: Future Profit|Expected Net Income HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Future Profit|Expected Net Profit Fate Therapeutics Corp (FATE)|Future Profit WHWK|Net Profit Forecast TCRX (TScan Therapeutics, Inc.)|Projected Future Earnings CSBR|XBIT - Expected Net Profit|CEL-SCI Corporation - Future Profit|Expected Net Income OSTX|radiopharmtheranostics.com - Projected Future Earnings|ARTV: Expected Profit|ANL (adlainortye.com) - Future Profit|VERU - Company Profit Forecast|TPST (Tempest Therapeutics, Inc.) - Projected Future Earnings|Projected Future Earnings xiliotx.com|Expected Profit Enochian BioSciences (RENB)|Expected Profit MURA (Mural Oncology PLC)|Expected Profit Kairos Pharma Ltd KAPA|Projected Future Earnings OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Projected Future Earnings|Company Profit Forecast Curis CRIS|APLM: Projected Future Earnings|Future Profit Tharimmune, Inc.|ADVB (Advanced Biomed) - Projected Future Earnings|Genprex - Forward Earnings|Expected Profit calidibio.com (CLDI)|Xenetic Biosciences, Inc. - Net Profit Forecast|Projected Future Earnings SLRX (salariuspharma.com)|Purple Biotech - Expected Profit|AONC: Future Profit|BGNE - Projected Future Earnings|CKPT (checkpointtx.com) - Future Profit|Expected Net Profit elevationoncology.com (ELEV)|Future Profit ICAD|ikenaoncology.com (IKNA) - Company Profit Forecast|Expected Profit Notable Labs, Ltd. (NTBL)|Expected Profit VIRX (Viracta Therapeutics, Inc.)|Projected Future Earnings MOR (MorphoSys Inc)|Projected Future Earnings NAYA Biosciences Inc NAYA|AAPGV - Expected Profit